Utama › Histiositosis Sel Langerhans › California
Kajian klinikal Histiositosis Sel Langerhans di California
3 kajian untuk Histiositosis Sel Langerhans sedang mencari peserta di lokasi di California.
Teks kajian rasmi (Bahasa Inggeris)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
- Kaiser Permanente Downey Medical Center, Downey
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- dan 6 lagi
Mengambil pesertaFasa 2
180 Days – 22 Years · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05828069Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Children's Hospital of Orange County, Orange
- UCSF Benioff Children's Hospital, San Francisco
Mengambil pesertaFasa 2
Semua umur · Semua jantina · Dikemas kini 18 Sep 2025 · NCT04079179Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- Stanford Children's Hospital, Lucile Packard Children's Hospital, Palo Alto
- Rady Children's Hospital - San Diego, San Diego
Mengambil pesertaFasa 3
Sehingga umur 21 · Semua jantina · Dikemas kini 11 Sep 2025 · NCT02670707Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.